Share on Google Plus 1 Share on Twitter 24 Share on Facebook 1 Share on LinkedIn 1 Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend 2 (29 Shares)  
Printer Friendly Page Save As Favorite View Favorites View Stats   2 comments

General News

Living on our tax dollars but fleeing them-- tax inverters AbbVie and Medtronic

By (about the author)     Permalink       (Page 1 of 2 pages)
Related Topic(s): ; ; ; ; ; ; ; ; , Add Tags Add to My Group(s)

View Ratings | Rate It

opednews.com Headlined to H2 8/23/14

Become a Fan
  (73 fans)
- Advertisement -

It's called "inversion" -- US corporations reincorporating in countries like Britain, Ireland or the Netherlands to duck US taxes, often by merging with a European entity.

The latest corporation to try to please investors with this tax dodge was Illinois-based Walgreen, the US's largest pharmacy chain. But this month, under accusations from customers and lawmakers that the maneuver was unpatriotic, unfair to corporations remaining in the US and hypocritical because most of its profits come from American households, Walgreen backed down.

The Illinois-based drug company AbbVie, on the other hand, is proceeding with its announced merger with the British drug company Shire, based on the small island of Jersey in the English Channel. The company "is expected to be resident in the UK for tax purposes," according to AbbVie's SEC filing. If the deal goes ahead, the company will have a bigger market value than Boeing, McDonald's and Cisco, writes The New York Times, totaling more than $137 billion.

AbbVie was spun off from North Chicago-based Abbott Laboratories in 2012 largely on the basis of Humira, a medication that treats autoimmune conditions like rheumatoid arthritis that's become the best-selling drug in the world.

Humira's success rests on two factors: Big Pharma's pursuit of costly biotech drugs (often earning $10,000 to $20,000 a year per patient) as blockbuster pills like Lipitor go off patent, and cagey marketing.

Though approved for the relatively rare conditions of rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and chronic plaque psoriasis, Humira became a best-seller with the help of the public relations giant Edelman and the health care advertising firm Harrison and Star, which gave it appeal beyond its limited indications.

Currently, AbbVie is raising "awareness" of the inflammatory bone and joint disease ankylosing spondylitis, which Humira happens to treat. Your back pain "may not be your fault" say AbbVie's ads; your pain may be caused not by muscle strain or a bad mattress but by a disease few had heard of -- until Humira's advertising blitz. The campaign even instructs listeners to tell their friends and family that their back pain may be from ankylosing spondylitis.



Drugs sold like soap by Martha Rosenberg

- Advertisement -

The AbbVie ad campaign raises ethical questions because the safety profiles of monoclonal antibody drugs, like Humira, that target the immune system are among the most concerning of all drugs, according to the FDA. While useful for autoimmune diseases, most experts agree that patients with less serious conditions should not be unnecessarily exposed to drugs with side effects like lymphoma, leukemia and super-infections.

And, speaking of ethics, questions about Shire, AbbVie's partner-to-be, have also been raised. Best known for its ADHD drugs Adderall, Vyvanse and Intuniv, in 2008 Shire launched a "Nationwide Adult ADHD Mobile Awareness Tour" called the RoADHD Trip. The caravan included tents with self-screening stations. A separate initiative included a "field-based team of experienced psychiatric nurses" who would "provide in-office education to physicians and their staff on ADHD in adults." ADHD is widely seen as overdiagnosed in the US.

In a conference call about its earnings, Shire bemoaned that it loses many of its college-age ADHD customers "as they kind of fall out of the system based on the fact that they no longer go to a pediatrician and they move on to a primary care physician." Soon ads with the slogan, "It's Your ADHD. Own It," telling young people they have not outgrown their ADHD, began appearing in college newspapers.

AbbVie's flight from US taxes to merge with Shire is especially hypocritical because in 2008 Abbott gave Humira free to elderly patients in order to churn demand while it successfully lobbied Congress to get Humira covered by Medicare. In addition to Medicare reimbursements, Humira costs state taxpayers as much as $50,000 per patient, according to a recent letter from pharmacies and insurers to Pennsylvania lawmakers.

AbbVie is also duking it out with drug maker Gilead over its uber-expensive hepatitis C treatment, Sovaldi. AbbVie claims it holds patents to the way the drug is administered.

- Advertisement -

Medtronic

As safety questions about medical devices continue to surface -- and some are replaced and withdrawn from the market -- "Big Device" companies are starting to look a lot like Big Pharma. So, it is no surprise that along with AbbVie -- and the drug companies Mylan, Jazz Pharmaceuticals, Actavis and Endo -- the device maker Medtronic is enacting a tax inversion and fleeing to Europe.

This summer, the Minneapolis-based medical device-manufacturer announced it was buying device-maker Covidien PLC which is "headquartered" in Massachusetts but is "domiciled" in Ireland.

Next Page  1  |  2

 

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon


Go To Commenting

The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact Author Contact Editor View Authors' Articles
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too

Comments

The time limit for entering new comments on this article has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

Comments: Expand   Shrink   Hide  
2 people are discussing this page, with 2 comments
To view all comments:
Expand Comments
(Or you can set your preferences to show all comments, always)

My book, Born with a Junk Food Deficiency, exposes... by Martha Rosenberg on Saturday, Aug 23, 2014 at 1:54:39 PM
to put it simply,the big corporations are traitors... by kappie on Monday, Aug 25, 2014 at 8:26:21 AM